Overview

Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects

Status:
Completed
Trial end date:
2021-07-15
Target enrollment:
Participant gender:
Summary
A single-center, open-label, randomized, two-period, crossover study design of pharmacokinetics and bioavailability in healthy Chinese subjects under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Collaborator:
Wenzhou Haihe Pharmaceutical Co., Ltd.
Treatments:
Eldecalcitol
Vitamin D